Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
Medtronic
Fish and Richardson
Baxter
US Department of Justice
UBS
Argus Health
Covington
Harvard Business School

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,968,507

« Back to Dashboard

Summary for Patent: 4,968,507
Title: Controlled porosity osmotic pump
Abstract:The instant invention is directed to an osmotic pump comprising: (A) at least one active agent surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6.96.times.10.sup.-18 to 6.96.times.10.sup.-14 cm.sup.3 sec/g and a reflection coefficient of less than 1, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0.1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.
Inventor(s): Zentner; Gaylen M. (Lawrence, KS), Rork; Gerald S. (Lawrence, KS), Himmelstein; Kenneth J. (Irvine, CA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:07/073,781
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 4,968,507

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,968,507

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 65910 ➤ Subscribe
Canada 1266827 ➤ Subscribe
Cyprus 1652 ➤ Subscribe
Germany 3583712 ➤ Subscribe
Denmark 175370 ➤ Subscribe
Denmark 276585 ➤ Subscribe
European Patent Office 0169105 ➤ Subscribe
Spain 544350 ➤ Subscribe
Spain 8704741 ➤ Subscribe
Hong Kong 57292 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Fuji
Argus Health
Mallinckrodt
Citi
UBS
Chinese Patent Office
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot